Albemarle (TICKER: ALB) Benchmark And Performance Data

there are 20 of samples in the benchmark for Albemarle in year 2022 in 2022. The total inventory for Albemarle was $798,620,000.00 in 2021. The total inventory for Albemarle was $768,984,000.00 in 2019. The total inventory for Albemarle was $750,237,000.00 in 2020. The total inventory for Albemarle was $700,540,000.00 in 2018. The total inventory for Albemarle was $592,781,000.00 in 2017. The total inventory for Albemarle was $450,263,000.00 in 2016. The total inventory for Albemarle was $439,513,000.00 in 2015. The total inventory for Albemarle was $436,049,000.00 in 2013. The total inventory for Albemarle was $428,145,000.00 in 2012. The total inventory for Albemarle was $358,361,000.00 in 2014. The sales, general, and administrative (SGA) for Albemarle was $533,368,000.00 in 2019. The sales, general, and administrative (SGA) for Albemarle was $450,286,000.00 in 2017. The sales, general, and administrative (SGA) for Albemarle was $446,090,000.00 in 2018. The sales, general, and administrative (SGA) for Albemarle was $441,482,000.00 in 2021. The sales, general, and administrative (SGA) for Albemarle was $429,827,000.00 in 2020. The sales, general, and administrative (SGA) for Albemarle was $355,135,000.00 in 2014. The sales, general, and administrative (SGA) for Albemarle was $353,765,000.00 in 2016. The sales, general, and administrative (SGA) for Albemarle was $308,456,000.00 in 2012. The sales, general, and administrative (SGA) for Albemarle was $300,440,000.00 in 2015. The sales, general, and administrative (SGA) for Albemarle was $158,189,000.00 in 2013. The sales, general, and administrative (SGA) for Albemarle was $$524,000,000 in 2022. The revenue volatility for Albemarle was 38.39% in 2022. The market capitalization for Albemarle was $30,977,823,800.00 in 2017. The market capitalization for Albemarle was $27,354,596,550.00 in 2014. The market capitalization for Albemarle was $26,177,380,600.00 in 2020. The market capitalization for Albemarle was $25,927,770,960.00 in 2019. The market capitalization for Albemarle was $25,899,318,800.00 in 2015. The market capitalization for Albemarle was $25,614,234,720.00 in 2013. The market capitalization for Albemarle was $25,405,754,906.00 in 2018. The market capitalization for Albemarle was $24,476,155,560.00 in 2016. The market capitalization for Albemarle was $19,953,645,621.00 in 2021. The market capitalization for Albemarle was $19,700,554,700.00 in 2012. The market capitalization for Albemarle was $$14,386,000,000 in 2022. The gross revenue for Albemarle was $3,589,427,000.00 in 2019. The gross revenue for Albemarle was $3,374,950,000.00 in 2018. The gross revenue for Albemarle was $3,327,957,000.00 in 2021. The gross revenue for Albemarle was $3,128,909,000.00 in 2020. The gross revenue for Albemarle was $3,071,976,000.00 in 2017. The gross revenue for Albemarle was $2,826,429,000.00 in 2015. The gross revenue for Albemarle was $2,677,203,000.00 in 2016. The gross revenue for Albemarle was $2,519,154,000.00 in 2012. The gross revenue for Albemarle was $2,445,548,000.00 in 2014. The gross revenue for Albemarle was $2,394,270,000.00 in 2013. The gross revenue for Albemarle was $$7,320,000,000 in 2022. The gross margin for Albemarle was $33.86% in 2022. The days sales outstanding for Albemarle was 44 days in 2022. The days payable outstanding for Albemarle was 92 days in 2022. The days of inventory for Albemarle was $124 in 2022. The cost of goods sold (COGS) for Albemarle was 58.00% in 2022. The cost of goods sold (COGS) for Albemarle was $2,331,649,000.00 in 2019. The cost of goods sold (COGS) for Albemarle was $2,329,986,000.00 in 2021. The cost of goods sold (COGS) for Albemarle was $2,157,694,000.00 in 2018. The cost of goods sold (COGS) for Albemarle was $2,134,056,000.00 in 2020. The cost of goods sold (COGS) for Albemarle was $1,966,196,000.00 in 2015. The cost of goods sold (COGS) for Albemarle was $1,965,700,000.00 in 2017. The cost of goods sold (COGS) for Albemarle was $1,706,897,000.00 in 2016. The cost of goods sold (COGS) for Albemarle was $1,674,700,000.00 in 2014. The cost of goods sold (COGS) for Albemarle was $1,620,311,000.00 in 2012. The cost of goods sold (COGS) for Albemarle was $1,543,799,000.00 in 2013. The cost of goods sold (COGS) for Albemarle was $$4,246,000,000 in 2022. The cash to cash cycle time for Albemarle was 76 in 2022. The annual percentage growth rate of Albemarle was -1.20% in 2022. Albemarle in its benchmark peer group, had rank 6 days for days sales outstanding in 2022. Albemarle in its benchmark peer group, had rank 20 for sales growth in 2022. Albemarle in its benchmark peer group, had rank 2 for cost of goods sold as a percent of revenue in 2022. Albemarle in its benchmark peer group, had rank 18 days for days of inventory in 2022. Albemarle in its benchmark peer group, had rank 14 for cash to cash cycle time in 2022. Albemarle in its benchmark peer group, had rank 11 for gross revenue in 2022. Albemarle headquarters region is South. Albemarle has ticker symbol ALB. Albemarle has the following profile: Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts.. Albemarle has primary indstury Specialty Chemicals. Albemarle had a $$5,168,000,000 gap between actual performance and next performance rank for gross revenue in competitive benchmarking in 2022. Albemarle had Eastman Chemical, and Albemarle, and Air Products & Chemicals, and RPM International Inc., and Avient, and Avantor, and International Flavors & Fragrances, and Stepan, and The Sherwin-Williams Company, and PPG Industries, Inc., and Element Solutions, and Cabot, and Ashland, and H.B. Fuller, and Olin Corporation, and DuPont, and Westlake Corporation, and NewMarket, and Chemours, and Ecolab benchmark peer companies for its SIC code in 2022. Albemarle had 7,400 number of employees in 2022. Albemarle had 54 days gap between actual performance and next performance rank for days of inventory in competitive benchmarking in 2022. Albemarle had 4 days gap between actual performance and next performance rank for days sales outstanding in competitive benchmarking in 2022. Albemarle had 27.23% gap between actual performance and next performance rank for sales volatility in competitive benchmarking in 2022. Albemarle had 15 days gap between actual performance and next performance rank for cash to cash in competitive benchmarking in 2022. Albemarle had 1.13% gap between actual performance and next performance rank for sales growth in competitive benchmarking in 2022. Albemarle had 0.00% gap between actual performance and next performance rank for gross margin in competitive benchmarking in 2022. Albemarle had 0.00% gap between actual performance and next performance rank for cost of goods sold as a percent of revenue in competitive benchmarking in 2022. Albemarle can reduce overall cost by $$137,000,000 by improving both COGS and SGA to next benchmark tier in 2022. Albemarle can reduce inventory with practices including SKU Reduction in 2022. Albemarle can reduce inventory with practices including Reduce Manufacturing Latency in 2022. Albemarle can reduce inventory with practices including Forecast Accuracy in 2022. Albemarle can reduce inventory with practices including Demand Shaping in 2022. Albemarle can reduce days sales outstanding with practices including in 2022. Albemarle can increase sales revenue by $$5,168,000,000 improving sales performance to next benchmark tier in 2022. Albemarle can increase revenue growth by $$83,000,000 by improving growth performance to next benchmark tier in 2022. Albemarle can increase overall revenue by $$5,251,000,000 by improving both growth and sales performance to next benchmark tier in 2022. Albemarle can increase days payables outstanding with practices including in 2022. Albemarle can increase days payables outstanding by $0 days by increasing days payables outstanding to next benchmark tier in 2022. Albemarle can improve total financial performance by $$6,552,000,000 by improving revenue, costs, and working capital in 2022. Albemarle can decrease overall working capital by $$1,163,000,000 by improving inventory, payables and receivables to next benchmark tier in 2022. Albemarle can decrease inventory days by $1,073,000,000 days by reducing inventory days to next benchmark tier in 2022. Albemarle can decrease days sales outstanding by $90,000,000 days by reducing days sales outstanding to next benchmark tier in 2022. Albemarle can accelerate revenue growth practices including Revenue-optimized Planning in 2022. Albemarle can accelerate revenue growth practices including Pricing Optimization in 2022. Albemarle can accelerate revenue growth practices including Accelerate Design Pipeline in 2022. 9.87% was the measured advantage or top third performance level for sales volatility in Albemarle's peer group in 2022. 70 days was the measured parity or middle performance level for days of inventory in Albemarle's peer group in 2022. 7.06% was the measured superior or top ten performance level for sales volatility in Albemarle's peer group in 2022. 69.81% was the measured parity or middle performance level for cost of goods sold as a percent of revenue in Albemarle's peer group in 2022. 64.04% was the measured advantage or top third performance level for cost of goods sold as a percent of revenue in Albemarle's peer group in 2022. 64 days was the measured advantage or top third performance level for days of inventory in Albemarle's peer group in 2022. 61.72% was the measured superior or top ten performance level for cost of goods sold as a percent of revenue in Albemarle's peer group in 2022. 61 days was the measured parity or middle performance level for cash to cash cycle time in Albemarle's peer group in 2022. 53 days was the measured parity or middle performance level for days sales outstanding in Albemarle's peer group in 2022. 49 days was the measured superior or top ten performance level for days of inventory in Albemarle's peer group in 2022. 48 days was the measured advantage or top third performance level for cash to cash cycle time in Albemarle's peer group in 2022. 45 days was the measured advantage or top third performance level for days sales outstanding in Albemarle's peer group in 2022. 40 days was the measured superior or top ten performance level for days sales outstanding in Albemarle's peer group in 2022. 32 days was the measured superior or top ten performance level for cash to cash cycle time in Albemarle's peer group in 2022. 19.74% was the measured superior or top ten performance level for gross margin in Albemarle's peer group in 2022. 11.16% was the measured parity or middle performance level for sales volatility in Albemarle's peer group in 2022. 0.02% was the measured superior or top ten performance level for sales growth in Albemarle's peer group in 2022. -0.06% was the measured parity or middle performance level for sales growth in Albemarle's peer group in 2022. -0.03% was the measured advantage or top third performance level for sales growth in Albemarle's peer group in 2022. $13.98% was the measured advantage or top third performance level for gross margin in Albemarle's peer group in 2022. $12.38% was the measured parity or middle performance level for gross margin in Albemarle's peer group in 2022. $$7,416,000,000 was the measured parity or middle performance level for gross revenue in Albemarle's peer group in 2022. $$15,980,000,000 was the measured superior or top ten performance level for gross revenue in Albemarle's peer group in 2022. $$12,488,000,000 was the measured advantage or top third performance level for gross revenue in Albemarle's peer group.